Monthly posts on new topics in delirium research

NIDUS Blog

Beyond delirium: The neuropsychiatric dimensions of COVID-19

Beyond delirium: The neuropsychiatric dimensions of COVID-19 By Mark Oldham, MD The data are clear and, sadly, just as clearly predictable.1,2 COVID-19 has caused delirium—lots of it in fact. Twenty to 30% of older adults with COVID-19 develop delirium, with older adults at higher risk of delirium than younger adults.3 Older adults with COVID-19 commonly […]

OCCUPATIONAL THERAPY: STRATEGIES FOR DELIRIUM MANAGEMENT

Contributed by Evelyn Alvarez1,2,3  & Juan Pablo Saa4 1 Centro de Estudios en Neurociencia Humana y Neuropsicología, Facultad de Psicología, Universidad Diego Portales, Chile, 2 Facultad de Ciencias de la Salud, Universidad Central de Chile, Chile, 3 Departamento de Terapia Ocupacional y Ciencia de la Ocupación, Facultad de Medicina, Universidad de Chile, Chile, 4 Florey […]

Line drawing of spotlight pointing to lower right corner

Delirium Research Hub Investigator Spotlight: Miles Berger

Every other month, the Delirium Research Hub selects an investigator and research study included in the Delirium Research Hub to feature as a Spotlight Investigator. This month, we are featuring Dr. Miles Berger, MD, PhD for his study “Markers of Alzheimer’s Disease and Cognitive Outcomes after Perioperative Care (MADCO-PC).” This study investigates whether changes in […]

Delirium Research Profile: Sangil Lee, MD

Hi everyone,   My name is Sangil Lee, and I am currently working at the University of Iowa Carver College of Medicine as a clinical associate professor.   Tell us how you got started in delirium research.   My passion for clinical research has been with me since I became a physician in 2005, when […]

Delirium severity: how do (or should) we conceptualise and measure it?

Contributed by Zoë Tieges, PhD, Psychology Research Fellow, Geriatric Medicine, Usher Institute, The University of Edinburgh Severity grading of delirium in research and clinical practice may have important value in monitoring clinical course and recovery, in providing prognostic information for risk stratification, in informing treatment, and as endpoints in clinical trials. Fine-grained measures of delirium […]

New Systematic Review of Instruments for Identification of Delirium

Contributed by Benjamin K. I. Helfand, MSc, MD/PhD (candidate), University of Massachusetts Medical School Delirium affects approximately 3 million older Americans annually, accounting for over $164 billion in healthcare expenditures.1 Delirium disproportionately affects our older population (over age 65) with major public health implications. Development of delirium is associated with prolonged hospitalization, cognitive decline, and […]

Delirium and the Power of Storytelling

Contributed by Heidi Lindroth, PhD RN, T32 Postdoctoral Fellow, Indiana University School of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Health Innovation and Implementation Science The COVID-19 pandemic has brought the terror of delirium to the forefront. Featured articles in the New York Times, the Atlantic, and others, have highlighted the enormous […]

Subscribe to our mailing list

* indicates required
Email Format

Login Status

Connect with